Cargando…

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) infections can lead to increased length of stay and mortality. Identification of the mechanism of resistance is vital to assist in antibiotic selection. In October 2021, our institution’s microbiology laboratory switched from the CARBA NP assay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burke, Elysia, Dutcher, Lauren, Hamilton, Keith W, Degnan, Kathleen, Glaser, Laurel, Maguire, Christina, Saw, Stephen, Mersinger, Katherine, Patel, Sonal, Athans, Vasilios, Binkley, Shawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677649/ http://dx.doi.org/10.1093/ofid/ofad500.2360

Ejemplares similares

1759. Risk Factors for OPAT-Related Adverse Drug Events: A Case-Control Study
por: Burke, Elysia, et al.
Publicado: (2022)

1012. Characterization of Antibiotic Superutilizers in the Inpatient Setting
por: Burns, Jonathan, et al.
Publicado: (2019)

275. Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia with a Deep-Seated Source
por: Mersinger, Katherine E, et al.
Publicado: (2020)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

168. Syndrome-Based Analysis of Oral Antimicrobial Stewardship Opportunities at Hospital Discharge
por: Cunningham, Jessica, et al.
Publicado: (2021)

905. Impact of a Real-Time Electronic Alert on Antibiotic Treatment Duration for Pneumonia in Hospitalized Patients
por: Degnan, Kathleen, et al.
Publicado: (2022)

751. Impact of Changing from a Three-step to Two-step Testing Algorithm for the Diagnosis of Clostridioides difficile
por: Lapin, Jonathan, et al.
Publicado: (2021)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

54. Effectiveness of a Venous Catheter Stewardship Intervention Targeting Parenteral Antimicrobial Therapy at Hospital Discharge
por: Athans, Vasilios, et al.
Publicado: (2020)

622. Evaluation of Vascular Access Device Selection in Patients Discharged on Outpatient Parenteral Antimicrobial Therapy
por: Hu, Jessica, et al.
Publicado: (2021)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
por: Black, Cody A., et al.
Publicado: (2021)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
por: Wielders, Cornelia C. H., et al.
Publicado: (2022)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales
por: Pudpong, Korawan, et al.
Publicado: (2022)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Clonal Dissemination of Multiple Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Mediated by Multiple Plasmids in China
por: Li, Jun, et al.
Publicado: (2021)

Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE)
por: Fitzpatrick, Margaret A., et al.
Publicado: (2022)

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa
por: Gill, Christian M., et al.
Publicado: (2023)

The Penn Medicine COVID-19 Therapeutics Committee—Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency
por: Anesi, George L, et al.
Publicado: (2023)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales
por: Hussein, Khetam, et al.
Publicado: (2022)

Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019–2021)
por: Sader, Helio S, et al.
Publicado: (2023)

Carbapenemase detection by NG-Test CARBA 5—a rapid immunochromatographic assay in carbapenem-resistant Enterobacterales diagnosis
por: Zhu, Ying, et al.
Publicado: (2021)

Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe
por: Shortridge, Dee, et al.
Publicado: (2022)

Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
por: Cahill, Niamh, et al.
Publicado: (2019)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

1218. Activity of Meropenem-Vaborbactam and Comparator Agents Against Carbapenemase-Negative, Carbapenem-Resistant Enterobacterales from US Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2021)

Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase
por: Abdelaziz, Neveen A.
Publicado: (2022)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
por: Bonnin, Rémy A., et al.
Publicado: (2023)

160. Antimicrobial Prescribing Patterns in Bloodstream Infections Caused by Cefepime-Susceptible Extended Spectrum β-lactamase Enterobacterales
por: O’Rourke, Emerald, et al.
Publicado: (2022)

202. Comparative Activity of Ceftazidime-Avibactam, Imipenem-Relebactam and Meropenem-Vaborbactam Tested Against Carbapenem-Nonsusceptible Enterobacterales that Are Carbapenemase-Negative
por: Castanheira, Mariana, et al.
Publicado: (2021)

Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy
por: Alqahtani, Hajar, et al.
Publicado: (2022)

Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases
por: Noster, Janina, et al.
Publicado: (2021)

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan
por: Habib, Amina, et al.
Publicado: (2022)

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
por: Alosaimy, Sara, et al.
Publicado: (2021)

2749. Disparities in Healthcare Seeking Behaviors in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED) Study
por: Schofield, Christina, et al.
Publicado: (2019)

118. Machine Learning Approaches to Predicting Treatment Outcomes for Carbapenem-Resistant Enterobacterales in a Region with High Prevalence of Non-Carbapenemase Producers
por: Black, Cody A, et al.
Publicado: (2021)

Carbapenemase investigation with rapid phenotypic test (RESIST-4 O.K.N.V) and comparison with PCR in carbapenem-resistant Enterobacterales strains
por: Yaşar-Duman, Melike, et al.
Publicado: (2022)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
por: Räisänen, Kati, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9q8vlfet3a6n3nsvoiujfp05j9